July 29, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
NEW YORK — GLP-1 receptor agonists offer dermatologic benefits but the same medications can leave patients grappling with several undesirable aesthetic outcomes, according to a speaker.“We know that weight reduction, while it can reduce systemic inflammation, can also cause negative effects as well,” Doris Day, MD, FAAD, professor of dermatology at the NYU Grossman School of
July 29, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known

As GLP-1 receptor agonists drive unprecedented weight loss, patients are achieving goal weights but face new aesthetic…

New research suggests that hair loss can be a real, if tiny, risk of starting a GLP-1 drug like Ozempic.

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically…

GLP-1 drugs such as Wegovy and Ozempic have been revolutionary for obesity and type 2 diabetes treatments, but questions remain…

GLP-1 receptor agonist therapy was associated with an increased risk for hair loss among adults with type 2 diabetes compared…